The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA

Human cytomegalovirus (HCMV) is a relevant pathogen, especially for individuals with impaired immunity. Harnessing potent immune antagonists, HCMV circumvents sterile immunity. Given that HCMV prevents the upregulation of human leukocyte antigen (HLA)-DP and HLA-DR, we screened a library of HCMV gen...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabienne Maassen, Vu Thuy Khanh Le-Trilling, Luisa Betke, Thilo Bracht, Corinna Siegmund, Malte Bayer, Benjamin Katschinski, Antonia Belter, Tanja Becker, Denise Mennerich, Sebastian Voigt, Lori Frappier, Barbara Sitek, Katharina Fleischhauer, Mirko Trilling
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2025-07-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/96414
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839640410892271616
author Fabienne Maassen
Vu Thuy Khanh Le-Trilling
Luisa Betke
Thilo Bracht
Corinna Siegmund
Malte Bayer
Benjamin Katschinski
Antonia Belter
Tanja Becker
Denise Mennerich
Sebastian Voigt
Lori Frappier
Barbara Sitek
Katharina Fleischhauer
Mirko Trilling
author_facet Fabienne Maassen
Vu Thuy Khanh Le-Trilling
Luisa Betke
Thilo Bracht
Corinna Siegmund
Malte Bayer
Benjamin Katschinski
Antonia Belter
Tanja Becker
Denise Mennerich
Sebastian Voigt
Lori Frappier
Barbara Sitek
Katharina Fleischhauer
Mirko Trilling
author_sort Fabienne Maassen
collection DOAJ
description Human cytomegalovirus (HCMV) is a relevant pathogen, especially for individuals with impaired immunity. Harnessing potent immune antagonists, HCMV circumvents sterile immunity. Given that HCMV prevents the upregulation of human leukocyte antigen (HLA)-DP and HLA-DR, we screened a library of HCMV genes by co-expression with the HLA class II (HLA-II)-inducing transcription coordinator class II transactivator (CIITA). We identified the latency regulator pUS28 as an interaction factor and potent viral antagonist of CIITA-driven expression of CD74, HLA-DR, HLA-DM, HLA-DQ, and HLA-DP. Both wt-pUS28 and a mutant incapable of inducing G protein-coupled signaling (R129A), but not a mutant lacking the C-terminus, drastically reduced the CIITA protein abundance post-transcriptionally. While control CD4 + T cells from HCMV-seropositive individuals vigorously responded to CIITA-expressing cells decorated with HCMV antigens, pUS28 expression was sufficient to inhibit HLA-II induction and immune recognition by HCMV-specific CD4 + T cells. Our data uncover pUS28 to be employed by HCMV to evade HLA-II-mediated recognition by CD4 + T cells.
format Article
id doaj-art-7d13baad636e4cb4ac2c27cba3bb1f95
institution Matheson Library
issn 2050-084X
language English
publishDate 2025-07-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj-art-7d13baad636e4cb4ac2c27cba3bb1f952025-07-03T15:01:46ZengeLife Sciences Publications LtdeLife2050-084X2025-07-011410.7554/eLife.96414The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITAFabienne Maassen0https://orcid.org/0009-0004-3535-3727Vu Thuy Khanh Le-Trilling1https://orcid.org/0000-0002-2733-3732Luisa Betke2https://orcid.org/0009-0008-6767-6239Thilo Bracht3Corinna Siegmund4https://orcid.org/0000-0002-1371-0779Malte Bayer5https://orcid.org/0000-0003-1060-8856Benjamin Katschinski6https://orcid.org/0000-0002-1314-2820Antonia Belter7https://orcid.org/0009-0005-4409-1447Tanja Becker8Denise Mennerich9Sebastian Voigt10Lori Frappier11Barbara Sitek12Katharina Fleischhauer13Mirko Trilling14https://orcid.org/0000-0003-3659-3541Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute for Experimental Cellular Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute for the Research on HIV and AIDS‐associated Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Experimental Cellular Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyMedizinisches Proteom Center, Ruhr University Bochum, Bochum, Germany; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyMedizinisches Proteom Center, Ruhr University Bochum, Bochum, Germany; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Molecular Genetics, University of Toronto, Toronto, CanadaMedizinisches Proteom Center, Ruhr University Bochum, Bochum, Germany; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, GermanyInstitute for Experimental Cellular Therapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Heidelberg, GermanyInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute for the Research on HIV and AIDS‐associated Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyHuman cytomegalovirus (HCMV) is a relevant pathogen, especially for individuals with impaired immunity. Harnessing potent immune antagonists, HCMV circumvents sterile immunity. Given that HCMV prevents the upregulation of human leukocyte antigen (HLA)-DP and HLA-DR, we screened a library of HCMV genes by co-expression with the HLA class II (HLA-II)-inducing transcription coordinator class II transactivator (CIITA). We identified the latency regulator pUS28 as an interaction factor and potent viral antagonist of CIITA-driven expression of CD74, HLA-DR, HLA-DM, HLA-DQ, and HLA-DP. Both wt-pUS28 and a mutant incapable of inducing G protein-coupled signaling (R129A), but not a mutant lacking the C-terminus, drastically reduced the CIITA protein abundance post-transcriptionally. While control CD4 + T cells from HCMV-seropositive individuals vigorously responded to CIITA-expressing cells decorated with HCMV antigens, pUS28 expression was sufficient to inhibit HLA-II induction and immune recognition by HCMV-specific CD4 + T cells. Our data uncover pUS28 to be employed by HCMV to evade HLA-II-mediated recognition by CD4 + T cells.https://elifesciences.org/articles/96414Human cytomegalovirusHCMVhuman herpesvirus 5HHV-5US28HLA class II
spellingShingle Fabienne Maassen
Vu Thuy Khanh Le-Trilling
Luisa Betke
Thilo Bracht
Corinna Siegmund
Malte Bayer
Benjamin Katschinski
Antonia Belter
Tanja Becker
Denise Mennerich
Sebastian Voigt
Lori Frappier
Barbara Sitek
Katharina Fleischhauer
Mirko Trilling
The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
eLife
Human cytomegalovirus
HCMV
human herpesvirus 5
HHV-5
US28
HLA class II
title The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
title_full The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
title_fullStr The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
title_full_unstemmed The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
title_short The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
title_sort human cytomegalovirus encoded pus28 antagonizes cd4 t cell recognition by targeting ciita
topic Human cytomegalovirus
HCMV
human herpesvirus 5
HHV-5
US28
HLA class II
url https://elifesciences.org/articles/96414
work_keys_str_mv AT fabiennemaassen thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT vuthuykhanhletrilling thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT luisabetke thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT thilobracht thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT corinnasiegmund thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT maltebayer thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT benjaminkatschinski thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT antoniabelter thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT tanjabecker thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT denisemennerich thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT sebastianvoigt thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT lorifrappier thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT barbarasitek thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT katharinafleischhauer thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT mirkotrilling thehumancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT fabiennemaassen humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT vuthuykhanhletrilling humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT luisabetke humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT thilobracht humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT corinnasiegmund humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT maltebayer humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT benjaminkatschinski humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT antoniabelter humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT tanjabecker humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT denisemennerich humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT sebastianvoigt humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT lorifrappier humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT barbarasitek humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT katharinafleischhauer humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita
AT mirkotrilling humancytomegalovirusencodedpus28antagonizescd4tcellrecognitionbytargetingciita